Rituximab/antineoplasticsCytomegalovirus infection and end-organ disease: 12 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-015-9303-z
中图分类号
学科分类号
摘要
引用
收藏
页码:212 / 212
相关论文
共 50 条
  • [34] Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response
    Ochodnicky, Peter
    Vettoretti, Simone
    Henning, Robert H.
    Buikema, Hendrik
    van Dokkum, Richard P. E.
    de Zeeuw, Dick
    JOURNAL OF NEPHROLOGY, 2006, 19 (03) : 246 - 258
  • [35] Cytomegalovirus end-organ disease in immunocompromised critically ill patients: key concerns demanding attention
    Zhihui Zhang
    Junlu Sun
    Xuesong Liu
    Rong Zhang
    Yimin Li
    Xiaoqing Liu
    Critical Care, 28 (1):
  • [37] Ambulatory Hypertension in Pediatric Patients With Sickle Cell Disease and Its Association With End-Organ Damage
    Ranabothu, Saritha
    Hafeman, Michael
    Manwani, Deepa
    Reidy, Kimberly
    Morrone, Kerry
    Lorenzo, Josemiguel
    Tria, Barbara
    Kaskel, Frederick
    Mahgerefteh, Joseph
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (11)
  • [38] Lowering blood pressure in coronary heart disease -: Treating symptoms or preventing end-organ complications
    Böhm, M
    HERZ KREISLAUF, 2000, 32 (04): : 121 - 122
  • [39] Endothelin blockers and renal protection: a new strategy to prevent end-organ damage in cardiovascular disease?
    Rabelink, TJ
    Stroes, ESG
    Bouter, KP
    Morrison, P
    CARDIOVASCULAR RESEARCH, 1998, 39 (03) : 543 - 549
  • [40] Challenging the status quo: a case for the lack of gut microbiota exacerbating hypertensive end-organ damage
    Xu, Chudan
    Marques, Francine Z.
    CARDIOVASCULAR RESEARCH, 2023, 119 (07) : 1455 - 1457